While AZ is eyeing overseas expansion with its new investment, J&J has embarked on a reshoring drive with a pledge to invest ...

Johnson & Johnson’s Stelara, Regeneron’s Eylea and Amgen’s Prolia are just some of the drugs facing off against new ...

Researchers have engineered yeast to efficiently convert methanol into D-lactic acid, a key compound for biodegradable plastics and pharmaceuticals. By optimizing gene and promoter combinations, they ...

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...

Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and Full Year 2024 Earnings Call. At this time, all lines are in ...

Johnson & Johnson has announced a $55 billion investment in the U.S. over the next four years. This move will boost American ...

In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

While patients clearly benefit from paying less for vital prescriptions, Congress also intended for 340B discounts to generate financial benefits for participating hospitals in tr ...

Some 750 companies, including Apple supplier Foxconn and Indian conglomerate Reliance Industries, signed up to the Production-Linked Initiative scheme, public records show ...

The tech industry – particularly Big Tech platforms such as Google and Meta – says it is being “coerced” into handing cash to ...